Fogler WE - Search Results

1

Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile.

Sim BK, Fogler WE, Zhou XH, Liang H, Madsen JW, Luu K, O'Reilly MS, Tomaszewski JE, Fortier AH. Sim BK, et al. Among authors: fogler we. Angiogenesis. 1999;3(1):41-51. doi: 10.1023/a:1009058931769. Angiogenesis. 1999. PMID: 14517443

2

Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.

Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fogler we. Clin Cancer Res. 2003 Oct 1;9(12):4619-26. Clin Cancer Res. 2003. PMID: 14555538

3

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development.

Plum SM, Holaday JW, Ruiz A, Madsen JW, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fogler we. Vaccine. 2000 Dec 8;19(9-10):1294-303. doi: 10.1016/s0264-410x(00)00210-3. Vaccine. 2000. PMID: 11137269

4

The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.

MacDonald NJ, Murad AC, Fogler WE, Lu Y, Sim BK. MacDonald NJ, et al. Among authors: fogler we. Biochem Biophys Res Commun. 1999 Oct 22;264(2):469-77. doi: 10.1006/bbrc.1999.1486. Biochem Biophys Res Commun. 1999. PMID: 10529387

5

Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.

Plum SM, Vu HA, Mercer B, Fogler WE, Fortier AH. Plum SM, et al. Among authors: fogler we. Immunopharmacol Immunotoxicol. 2004 Feb;26(1):29-41. doi: 10.1081/iph-120029942. Immunopharmacol Immunotoxicol. 2004. PMID: 15106730

6

Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis.

Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ. Shah JH, et al. Among authors: fogler we. J Med Chem. 1999 Aug 12;42(16):3014-7. doi: 10.1021/jm990083y. J Med Chem. 1999. PMID: 10447943 No abstract available.

7

Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study.

Beerepoot LV, Witteveen EO, Groenewegen G, Fogler WE, Sim BK, Sidor C, Zonnenberg BA, Schramel F, Gebbink MF, Voest EE. Beerepoot LV, et al. Among authors: fogler we. Clin Cancer Res. 2003 Sep 15;9(11):4025-33. Clin Cancer Res. 2003. PMID: 14519623 Clinical Trial.

8

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.

Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie-Shepherd SR, Folkman J. Kisker O, et al. Among authors: fogler we. Cancer Res. 2001 Oct 15;61(20):7669-74. Cancer Res. 2001. PMID: 11606410

9

Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.

Plum SM, Park EJ, Strawn SJ, Moore EG, Sidor CF, Fogler WE. Plum SM, et al. Among authors: fogler we. BMC Musculoskelet Disord. 2009 May 1;10:46. doi: 10.1186/1471-2474-10-46. BMC Musculoskelet Disord. 2009. PMID: 19409094 Free PMC article.

10

Anti-angiogenic vaccines as a treatment modality for cancer.

Plum SM, Fogler WE. Plum SM, et al. Among authors: fogler we. Curr Opin Investig Drugs. 2004 Dec;5(12):1243-6. Curr Opin Investig Drugs. 2004. PMID: 15648944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters